Literature DB >> 17017199

Efficacy of laser trabeculoplasty in phakic and pseudophakic patients with primary open-angle glaucoma.

Sheila Mahdaviani1, Naris Kitnarong, Justin K Kropf, Peter A Netland.   

Abstract

BACKGROUND AND
OBJECTIVE: To compare the efficacy of laser trabeculoplasty in pseudophakic and phakic patients with primary open-angle glaucoma (POAG). PATIENTS AND METHODS: Retrospective comparative case-control series of 42 eyes (21 pseudophakic eyes and 21 phakic eyes of patients matched for age and gender) with POAG not controlled using medical therapy and treated with laser trabeculoplasty. Success was reduction of intraocular pressure (IOP) of at least 3 mm Hg from baseline and no additional glaucoma surgery or laser treatment. uloplasty, there was no significant difference between pseudophakic and phakic eyes in the mean IOP and change from baseline IOP Success at 12 months was 78% for pseudophakic and 80% for phakic eyes. Kaplan-Meier survival analysis showed no statistically significant difference in success after laser trabeculoplasty comparing phakic to pseudophakic eyes (P = .87).
CONCLUSION: In eyes with POAG, laser trabeculoplasty is as effective in pseudophakic eyes as in phakic eyes.

Entities:  

Mesh:

Year:  2006        PMID: 17017199     DOI: 10.3928/15428877-20060901-06

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  3 in total

1.  Selective laser trabeculoplasty in pseudophakic and phakic eyes: a prospective study.

Authors:  Myrjam De Keyser; Maya De Belder; Veva De Groot
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

2.  [Effectiveness of selective laser trabeculoplasty in patients with insufficient control of intraocular pressure despite maximum tolerated medical therapy].

Authors:  C Hirn; S A Zweifel; M Töteberg-Harms; J Funk
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

3.  A new manner of reporting pressure results after glaucoma surgery.

Authors:  Constantin-Dan Bordeianu; Cristina-Eugenia Ticu
Journal:  Clin Ophthalmol       Date:  2011-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.